Advances in stem cell therapy for amyotrophic lateral sclerosis

References

• Brown RH Jr., Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. United States. 2017;377(16):1602.
   PubMedGoogle Scholar
• Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012 Mar 14; (3). CD001447. Doi:10.1002/14651858.CD001447.pub3.
   Web of Science ®Google Scholar
• Al-Chalabi A, Andersen PM, Chandran S, et al. ENCALS statement on edaravone. Amyotroph Lateral Scler Frontotemporal Degener. 2017 July;18(7–8):471–474. Epub 2017 Oct 4.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016 Nov;539(7628):197–206.
   PubMed Web of Science ®Google Scholar
• Kang SH, Li Y, Fukaya M, et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013 May;16(5):571–579.
   PubMed Web of Science ®Google Scholar
• Serio A, Patani R. Concise review:The cellular conspiracy of amyotrophic lateral sclerosis. Stem Cells. 2018 Mar;36(3):293–303.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Boillee S, Roberts EA, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A. 2008 May;105(21):7594–7599.
   PubMed Web of Science ®Google Scholar
• Boillee S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006 Jun 2;312(5778):1389–1392.
   PubMed Web of Science ®Google Scholar
• Frakes AE, Ferraiuolo L, Haidet-Phillips AM, et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014 Mar 5;81(5):1009–1023.
   PubMed Web of Science ®Google Scholar
• Howland DS, Liu J, She Y, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A. 2002 Feb;99(3):1604–1609.
   PubMed Web of Science ®Google Scholar
• Haidet-Phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011 Aug;29(9):824–828.
   PubMed Web of Science ®Google Scholar
• Lepore AC, Rauck B, Dejea C, et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci. 2008 Nov;11(11):1294–1301.
   PubMed Web of Science ®Google Scholar
• Meyer K, Ferraiuolo L, Miranda CJ, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):829–832.
   PubMed Web of Science ®Google Scholar
• Hu Y, Cao C, Qin XY, et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep. 2017 Aug;7(1):9094.
   PubMed Web of Science ®Google Scholar
• Bataveljić D, Nikolić L, Milosević M, et al. Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model. Glia. 2012 Dec;60(12):1991–2003.
   PubMed Web of Science ®Google Scholar
• Pollari E, Goldsteins G, Bart G, et al. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci. 2014;8:131.
   PubMed Web of Science ®Google Scholar
• Suttkus A, Rohn S, Weigel S, et al. Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress. Cell Death Dis. 2014;5:e1119.
   PubMed Web of Science ®Google Scholar
• Forostyak S, Homola A, Turnovcova K, et al. Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS. Stem Cells. 2014;32(12):3163–3172.
   PubMed Web of Science ®Google Scholar
• Bortolotto V, Cuccurazzu B, Canonico PL, et al. NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity. Biomed Res Int. 2014;2014:612798.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhang W, Yang P. Current states of endogenous stem cells in adult spinal cord. J Neurosci Res. 2015 Mar;93(3):391–398. . Epub 2014 Sep 16.
   PubMed Web of Science ®Google Scholar
• Ferrucci M, Ryskalin L, Busceti CL, et al. Are there endogenous stem cells in the spinal cord?. Arch Ital Biol. 2017 Dec 1;155(4):118–130.
   Web of Science ®Google Scholar
• Wautier F, Wislet-Gendebien S, Chanas G, et al. Regulation of nestin expression by thrombin and cell density in cultures of bone mesenchymal stem cells and radial glial cells. BMC Neurosci. 2007 Nov;30(8):104.
   Web of Science ®Google Scholar
• Meletis K, Barnabé-Heider F, Carlén M, et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 2008 Jul 22;6(7):e182. .
   PubMed Web of Science ®Google Scholar
• Liu S, Sarkar C, Dinizo M, et al. Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death. Cell Death Dis. 2015 Jan 8;6: e1582. .
   PubMed Web of Science ®Google Scholar
• Peters S, Zitzelsperger E, Kuespert S, et al. The TGF-β system as a potential pathogenic player in disease modulation of amyotrophic lateral sclerosis. Front Neurol. 2017;8:669.
   PubMed Web of Science ®Google Scholar
• Abdulla S, Machts J, Kaufmann J, et al. Hippocampal degeneration in patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2014 Nov;35(11):2639–2645. Epub 2014 Jun 11.
   PubMed Web of Science ®Google Scholar
• Quarta E, Bravi R, Scambi I, et al. Increased anxiety-like behavior and selective learning impairments are concomitant to loss of hippocampal interneurons in the presymptomatic SOD1(G93A) ALS mouse model. J Comp Neurol. 2015 Aug 1;523(11):1622–1638. . Epub 2015 Apr 7.
   PubMed Web of Science ®Google Scholar
• Galán L, Gómez-Pinedo U, Guerrero A, et al. Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches. BMC Neurol. 2017 Sep 6;17(1):173.
   PubMed Web of Science ®Google Scholar
• Liu Z, Martin LJ. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain. J Comp Neurol. 2006 Jul 20;497(3):468–488.
   PubMed Web of Science ®Google Scholar
• Li R, Strykowski R, Meyer M, et al. Male-specific differences in proliferation, neurogenesis, and sensitivity to oxidative stress in neural progenitor cells derived from a rat model of ALS. PLoS One. 2012;7(11):e48581. . Epub 2012 Nov 8
   PubMed Web of Science ®Google Scholar
• Vescovi AL, Parati EA, Gritti A, et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol. 1999 Mar;156(1):71–83.
   PubMed Web of Science ®Google Scholar
• Guo X, Johe K, Molnar P, et al. Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons. J Tissue Eng Regen Med. 2010 Mar;4(3):181–193.
   PubMed Web of Science ®Google Scholar
• Gelati M, Profico D, Projetti-Pensi M, et al. Culturing and expansion of “clinical grade” precursors cells from the fetal human central nervous system. Methods Mol Biol. 2013;1059:65–77.
   PubMedGoogle Scholar
• Feldman EL, Boulis NM, Hur J, et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol. 2014 Mar;75(3):363–373.
   PubMed Web of Science ®Google Scholar
• Glass JD, Hertzberg VS, Boulis NM, et al. Transplantation of spinal cord-derived neural stem cells for ALS: analysis of phase 1 and 2 trials. Neurology. 2016 Jul 26;87(4):392–400.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Gelati M, Profico DC, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13(1):17.
   PubMed Web of Science ®Google Scholar
• Kondo T, Funayama M, Tsukita K, et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Rep. 2014 Aug;3(2):242–249.
   PubMed Web of Science ®Google Scholar
• Foroni C, Galli R, Cipelletti B, et al. Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo. Cancer Res. 2007 Apr;67(8):3725–3733.
   PubMed Web of Science ®Google Scholar
• Diaferia GR, Conti L, Redaelli S, et al. Systematic chromosomal analysis of cultured mouse neural stem cell lines. Stem Cells Dev. 2011 Aug;20(8):1411–1423.
   PubMed Web of Science ®Google Scholar
• Rota Nodari L, Ferrari D, Giani F, et al. Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS One. 2010;5(11):e14035.
   PubMed Web of Science ®Google Scholar
• Xu L, Yan J, Chen D, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation. 2006 Oct;82(7):865–875.
   PubMed Web of Science ®Google Scholar
• Teng YD, Benn SC, Kalkanis SN, et al. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med. 2012 Dec;4(165):165ra64.
   Web of Science ®Google Scholar
• Knippenberg S, Rath KJ, Böselt S, et al. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors. J Tissue Eng Regen Med. 2015 Jan;11(3):751–764.
   PubMed Web of Science ®Google Scholar
• Thomsen GM, Avalos P, Ma AA, et al. Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cells. 2018 Apr 15. DOI:10.1002/stem.2825.
   PubMed Web of Science ®Google Scholar
• Mitrecić D, Nicaise C, Gajović S, et al. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant. 2010;19(5):537–548.
   PubMed Web of Science ®Google Scholar
• Nicaise C, Mitrecic D, Pochet R. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. Neuropathol Appl Neurobiol. 2011 Feb;37(2):179–188.
   PubMed Web of Science ®Google Scholar
• Giusto E, Donega M, Cossetti C, et al. Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol. 2014 Oct;260:19–32.
   PubMed Web of Science ®Google Scholar
• Lech W, Figiel-Dabrowska A, Sarnowska A, et al. Phenotypic, functional, and safety control at preimplantation phase of MSC-based therapy. Stem Cells Int. 2016;2016:2514917.
   PubMed Web of Science ®Google Scholar
• Weiss ML, Anderson C, Medicetty S, et al. Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells. 2008 Nov;26(11):2865–2874.
   PubMed Web of Science ®Google Scholar
• Drela K, Lech W, Figiel-Dabrowska A, et al. Enhanced neuro-therapeutic potential of Wharton’s Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture. Cytotherapy. 2016 Apr;18(4):497–509.
   PubMed Web of Science ®Google Scholar
• Donders R, Bogie JFJ, Ravanidis S, et al. Human wharton’s jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compared to bone marrow-derived stem cells. Stem Cells Dev. 2018 Jan;27(2):65–84.
   PubMed Web of Science ®Google Scholar
• Noël D, Caton D, Roche S, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res. 2008 Apr;314(7):1575–1584.
   PubMed Web of Science ®Google Scholar
• Chen G, Yue A, Ruan Z, et al. Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium. PLoS One. 2014;9(6):e98565.
   PubMed Web of Science ®Google Scholar
• Obtulowicz P, Lech W, Strojek L, et al. Induction of endothelial phenotype from Wharton’s Jelly-derived MSCs and comparison of their vasoprotective and neuroprotective potential with primary WJ-MSCs in CA1 hippocampal region ex vivo. Cell Transplant. 2016;25(4):715–727.
   PubMed Web of Science ®Google Scholar
• Knippenberg S, Thau N, Schwabe K, et al. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis. 2012;9(3):107–120.
   PubMed Web of Science ®Google Scholar
• Bigini P, Veglianese P, Andriolo G, et al. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration. Rejuvenation Res. 2011 Dec;14(6):623–639.
   PubMed Web of Science ®Google Scholar
• Sironi F, Vallarola A, Violatto MB, et al. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice. Stem Cell Res. 2017;25:166–178.
   PubMed Web of Science ®Google Scholar
• Marconi S, Bonaconsa M, Scambi I, et al. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 2013;248:333–343.
   PubMed Web of Science ®Google Scholar
• Lopez-Verrilli MA, Caviedes A, Cabrera A, et al. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience. 2016 Apr;320:129–139.
   PubMed Web of Science ®Google Scholar
• Sanchez V, Villalba N, Fiore L, et al. Characterization of tunneling nanotubes in Wharton’s jelly mesenchymal stem cells an intercellular exchange of components between neighboring cells. Stem Cell Rev. 2017 Aug;13(4):491–498.
   PubMed Web of Science ®Google Scholar
• Bahrami N, Bayat M, Mohamadnia A, et al. Purmorphamine as a Shh signaling activator small molecule promotes motor neuron differentiation of mesenchymal stem cells cultured on nanofibrous PCL scaffold. Mol Neurobiol. 2017 Sep;54(7):5668–5675.
   PubMed Web of Science ®Google Scholar
• Boulland JL, Mastrangelopoulou M, Boquest AC, et al. Epigenetic regulation of nestin expression during neurogenic differentiation of adipose tissue stem cells. Stem Cells Dev. 2013 Apr 1;22(7):1042–1052. .
   PubMed Web of Science ®Google Scholar
• Yang H, Wang G, Sun H, et al. Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res. 2014 Apr;24(4):464–481.
   PubMed Web of Science ®Google Scholar
• Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008 Aug 29;321(5893):1218–1221.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen J, Li X, et al. [Generation of induced pluripotent stem cells from amyotrophic lateral sclerosis patient carrying SOD1-V14M mutation]. Zhonghua Yi Xue Za Zhi. 2014 Jul 15;94(27):2143–2147.
   PubMedGoogle Scholar
• Wainger BJ, Kiskinis E, Mellin C, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014 Apr 10;7(1):1–11.
   PubMed Web of Science ®Google Scholar
• Mitne-Neto M, Machado-Costa M, Marchetto MC, et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet. 2011 Sep 15;20(18):3642–3652.
   PubMed Web of Science ®Google Scholar
• Bilican B, Serio A, Barmada SJ, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5803–5808.
   PubMed Web of Science ®Google Scholar
• Egawa N, Kitaoka S, Tsukita K, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012 Aug 1;4(145):145ra04.
   Web of Science ®Google Scholar
• Almeida S, Gascon E, Tran H, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013 Sep;126(3):385–399.
   PubMed Web of Science ®Google Scholar
• Donnelly CJ, Zhang PW, Pham JT, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013 Oct 16;80(2):415–428.
   PubMed Web of Science ®Google Scholar
• Sareen D, O’Rourke JG, Meera P, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013 Oct 23;5(208):208ra149.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen J, Liu W, et al. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation. Neurogenetics. 2015 Jul;16(3):223–231.
   PubMed Web of Science ®Google Scholar
• Burkhardt MF, Martinez FJ, Wright S, et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2013;56:355–364.
   PubMed Web of Science ®Google Scholar
• Alves CJ, Dariolli R, Jorge FM, et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front Cell Neurosci. 2015;9:289.
   PubMedGoogle Scholar
• Devlin AC, Burr K, Borooah S, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015 Jan 12;6:5999.
   PubMed Web of Science ®Google Scholar
• Re DB, le Verche V, Yu C, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014 Mar 5;81(5):1001–1008.
   PubMed Web of Science ®Google Scholar
• Glover JC, Sato K, Momose-Sato Y. Using voltage-sensitive dye recording to image the functional development of neuronal circuits in vertebrate embryos. Dev Neurobiol. 2008 May;68(6):804–816.
   PubMed Web of Science ®Google Scholar
• Maioli M, Rinaldi S, Santaniello S, et al. Radio electric conveyed fields directly reprogram human dermal skin fibroblasts toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant. 2013;22(7):1227–1235.
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Maioli M, Pigliaru G, et al. Stem cell senescenceEffects of REAC technology on telomerase-independent and telomerase-dependent pathways. Sci Rep. 2014 Sep;16(4):6373.
   Google Scholar
• Maioli M, Rinaldi S, Migheli R, et al. Neurological morphofunctional differentiation induced by REAC technology in PC12 A neuro protective model for Parkinson’s disease. Sci Rep. 2015 May;15(5):10439.
   Web of Science ®Google Scholar
• Maioli M, Rinaldi S, Santaniello S, et al. Radioelectric asymmetric conveyed fields and human adipose-derived stem cells obtained with a nonenzymatic method and device: a novel approach to multipotency. Cell Transplant. 2014;23(12):1489–1500.
   PubMed Web of Science ®Google Scholar
• Maioli M, Rinaldi S, Pigliaru G, et al. REAC technology and hyaluron synthase 2, an interesting network to slow down stem cell senescence. Sci Rep. 2016 Jun 24;6:28682.
   PubMed Web of Science ®Google Scholar
• Collodel G, Fioravanti A, Pascarelli NA, et al. Effects of regenerative radioelectric asymmetric conveyer treatment on human normal and osteoarthritic chondrocytes exposed to IL-1beta. A biochemical and morphological study. Clin Interv Aging. 2013;8:309–316.
   PubMed Web of Science ®Google Scholar
• Di Lullo E, Kriegstein AR. The use of brain organoids to investigate neural development and disease. Nat Rev Neurosci. 2017 Oct;18(10):573–584.
   PubMed Web of Science ®Google Scholar
• Fl M, Al R, Cl P, et al. Integrating biomaterials and stem cells for neural regeneration. Stem Cells Dev. 2016 Feb 1;25(3):214–226.
   PubMed Web of Science ®Google Scholar
• Ishihara K, Ranga A, Lutolf MP, et al. Reconstitution of a patterned neural tube from single mouse embryonic stem cells. Methods Mol Biol. 2017;1597:43–55.
   PubMedGoogle Scholar
• Mazibuko Z, Choonara YE, Kumar P, et al. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr;104(4):1213–1229.
   PubMed Web of Science ®Google Scholar
• Garcia-Bennett AE, Konig N, Abrahamsson N, et al. In vitro generation of motor neuron precursors from mouse embryonic stem cells using mesoporous nanoparticles. Nanomedicine (Lond). 2014 Nov;9(16):2457–2466.
   PubMed Web of Science ®Google Scholar
• Garcia-Bennett AE, Kozhevnikova M, Konig N, et al. Delivery of differentiation factors by mesoporous silica particles assists advanced differentiation of transplanted murine embryonic stem cells. Stem Cells Transl Med. 2013 Nov;2(11):906–915.
   Web of Science ®Google Scholar
• Baghirov H, Karaman D, Viitala T, et al. Feasibility study of the permeability and uptake of mesoporous silica nanoparticles across the blood-brain barrier. PLoS One. 2016;11(8):e0160705.
   PubMed Web of Science ®Google Scholar
• Gonzalez Porras MA, Durfee PN, Gregory AM, et al. A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells. J Neurosci Methods. 2016 Nov;1(273):160–174.
   Web of Science ®Google Scholar
• Vegh I, Grau M, Gracia M, et al. Decidua mesenchymal stem cells migrated toward mammary tumors in vitro and in vivo affecting tumor growth and tumor development. Cancer Gene Ther. 2013 Jan;20(1):8–16.
   PubMed Web of Science ®Google Scholar
• Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 2015;77:13–27.
   PubMed Web of Science ®Google Scholar
• Bonafede R, Scambi I, Peroni D, et al. Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res. 2016 Jan 1;340(1):150–158.
   PubMed Web of Science ®Google Scholar
• Pinto S, Cunha C, Barbosa M, et al. Exosomes from NSC-34 Cells Transfected with hSOD1-G93A are enriched in miR-124 and drive alterations in microglia phenotype. Front Neurosci. 2017;11:273.
   PubMed Web of Science ®Google Scholar
• Basso M, Pozzi S, Tortarolo M, et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013 May 31;288(22):15699–15711.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011 Apr;29(4):341–345.
   PubMed Web of Science ®Google Scholar
• Lee M, Ban JJ, Kim KY, et al. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem Biophys Res Commun. 2016 Oct 21;479(3):434–439.
   PubMed Web of Science ®Google Scholar
• Madison RD, McGee C, Rawson R, et al. Extracellular vesicles from a muscle cell line (C2C12) enhance cell survival and neurite outgrowth of a motor neuron cell line (NSC-34). J Extracell Vesicles. 2014;3:1–9.
   Google Scholar
• Mazzini L, Fagioli F, Boccaletti R, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):158–161.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Ferrero I, Luparello V, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol. 2010 May;223(1):229–237.
   PubMed Web of Science ®Google Scholar
• Prabhakar S, Marwaha N, Lal V, et al. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study. Neurol India. 2012 Sep-Oct;60(5):465–469.
   PubMed Web of Science ®Google Scholar
• Oh KW, Moon C, Kim HY, et al. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl Med. 2015 Jun;4(6):590–597.
   PubMed Web of Science ®Google Scholar
• Sharma AK, Sane HM, Paranjape AA, et al. The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study. Am J Stem Cells. 2015;4(1):50–65.
   PubMed Web of Science ®Google Scholar
• Rushkevich YN, Kosmacheva SM, Zabrodets GV, et al. The use of autologous mesenchymal stem cells for cell therapy of patients with amyotrophic lateral sclerosis in Belarus. Bull Exp Biol Med. 2015 Aug;159(4):576–581.
   PubMed Web of Science ®Google Scholar
• Sykova E, Rychmach P, Drahoradova I, et al. Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I/IIa clinical Trial. Cell Transplant. 2017 Apr 13;26(4):647–658.
   PubMed Web of Science ®Google Scholar
• Staff NP, Madigan NN, Morris J, et al. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology. 2016 Nov 22;87(21):2230–2234.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mareschi K, Ferrero I, et al. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy. 2012 Jan;14(1):56–60.
   PubMed Web of Science ®Google Scholar
• Blanquer MI, Pérez EMA, Iniesta F, et al. Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial. Methods Find Exp Clin Pharmacol. 2010 Dec;32(Suppl):A:31–7.
   PubMedGoogle Scholar
• Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, et al. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy. 2009;11(1):26–34.
   PubMed Web of Science ®Google Scholar
• Martinez HR, Molina-Lopez JF, Gonzalez-Garza MT, et al. Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility. Cell Transplant. 2012;21(9):1899–1907.
   PubMed Web of Science ®Google Scholar
• Appel SH, Engelhardt JI, Henkel JS, et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 2008 Oct 21;71(17):1326–1334.
   PubMed Web of Science ®Google Scholar
• Deda H, Inci MC, Kurekci AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11(1):18–25.
   PubMed Web of Science ®Google Scholar
• Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010 Oct;67(10):1187–1194.
   PubMed Web of Science ®Google Scholar
• Petrou P, Gothelf Y, Argov Z, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol. 2016 Mar;73(3):337–344.
   PubMed Web of Science ®Google Scholar
• Moviglia GA, Moviglia-Brandolino MT, Varela GS, et al. Feasibility, safety, and preliminary proof of principles of autologous neural stem cell treatment combined with T-cell vaccination for ALS patients. Cell Transplant. 2012;21(Suppl 1):S57–63.
   PubMed Web of Science ®Google Scholar
• Cashman N, Tan LY, Krieger C, et al. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve. 2008 May;37(5):620–625.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang L, Fu Y, et al. Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5–6):430–431.
   PubMed Web of Science ®Google Scholar
• Nefussy B, Artamonov I, Deutsch V, et al. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study. Amyotroph Lateral Scler. 2010;11(1–2):187–193.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, la Bella V, et al. Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve. 2011 Feb;43(2):189–195.
   PubMed Web of Science ®Google Scholar
• Huang H, Chen L, Xi H, et al. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant. 2008 [2008 Nov-Dec];22(6):710–718.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen D, Xi H, et al. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations. Cell Transplant. 2012;21(Suppl 1):S65–77.
   PubMed Web of Science ®Google Scholar
• Piepers S, Van Den Berg LH. No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS. Amyotroph Lateral Scler. 2010 May;11(3):328–330.
   PubMed Web of Science ®Google Scholar
• Chew S, Khandji AG, Montes J, et al. Olfactory ensheathing glia injections in Beijing: misleading patients with ALS. Amyotroph Lateral Scler. 2007 Oct;8(5):314–316.
   PubMed Web of Science ®Google Scholar
• Glass JD, Boulis NM, Johe K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells. 2012 Jun;30(6):1144–1151.
   PubMed Web of Science ®Google Scholar
• Tadesse T, Gearing M, Senitzer D, et al. Analysis of graft survival in a trial of stem cell transplant in ALS. Ann Clin Transl Neurol. 2014 Nov;1(11):900–908.
   PubMed Web of Science ®Google Scholar
• Blanquer M, Moraleda JM, Iniesta F, et al. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells. 2012 Jun;30(6):1277–1285.
   PubMed Web of Science ®Google Scholar
• Vercelli A, Mereuta OM, Garbossa D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008 Sep;31(3):395–405.
   PubMed Web of Science ®Google Scholar
• Boido M, Piras A, Valsecchi V, et al. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. Cytotherapy. 2014 Aug;16(8):1059–1072.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Milanese M, Principato MC, et al. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med. 2012 Jul;18(18):794–804.
   PubMed Web of Science ®Google Scholar
• Atassi N, Beghi E, Blanquer M, et al. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: ready for efficacy clinical trials? Cytotherapy. 2016 Dec;18(12):1471–1475.
   PubMed Web of Science ®Google Scholar
• Regulation (EC). No 1394/2007 of the European parliament and of the council of 13 November 2007 on advanced therapy medicinal products and amending directive 2001/83/ECand Regulation (EC) No 726/2004. Official J. Eur. Union L 324. Available at http://eurlex.europa.eu/LexUrServ/LexUriServ.do?uri=OJ:L: 2007; 324(0121): 0137. en:PDF accessed 2014 Jan 07.
   Google Scholar
• Commission Directive. 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products. Official Journal L 242. 2009 Sept 15; 3–12.
   Google Scholar
• EudraLex. The rules governing medicinal products in the European Union. Volume 1: EU pharmaceutical legislation for medicinal products for human use and Volume 10. Clinical trials guidelines.
   Google Scholar
• Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Guideline for good clinical practice E6(R2). European Medicines Agency. Committee for Human Medicinal Products. EMA/CHMP/ICH/135/1995. Published 1 Dec 2016.
   Google Scholar
• Directive. 2001/20/ECof the European parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Med Etika Bioet. 2002 Spring-Summer;9(1–2):12–19.
   Google Scholar
• Daley GQ, Hyun I, Apperley JF, et al. Setting global standards for stem cell research and clinical translation: The 2016 ISSCR guidelines. Stem Cell Rep. 2016 Jun 14;6(6):787–797.
   PubMed Web of Science ®Google Scholar
• Cossu G, Birchall M, Brown T, et al. Lancet commission: Stem cells and regenerative medicine. Lancet. 2018 Mar 3;391(10123):883–910.
   PubMed Web of Science ®Google Scholar
• Cote DJ, Bredenoord AL, Smith TR, et al. Ethical clinical translation of stem cell interventions for neurologic disease. Neurology. 2017 Jan;88(3):322–328.
   PubMed Web of Science ®Google Scholar